8 results
The primary objective of this study is to test the hypothesis that treatment with LY3074828 is superior to placebo in inducing clinical remission at Week 12 in subjects with moderate to severe ulcerative colitis (UC).The secondary objectives are:-To…
To test the hypothesis that mirikizumab is superior to placebo in inducing clinical remission at Week 12 in patients with moderately to severely active ulcerative colitis (UC)
The main objectives of this study are to determine the accuracy of the device (1) to determine functional oxygen saturation (SpO2) compared to a reference device, and (2) to determine respiratory rate compared to visual observations. As a secondary…
The main objective of this study is to validate the accuracy of the device to monitor the physical activity of a subject by comparing the measured values to the golden standard (video recording).
Primary Objective: To study whether the pulse oximeter functionality of the wearable ear sensor is able to reliably measure oxygen saturation, pulse rate, and respiratory rate in a clinical (postoperative) setting.Secondary Objective(s): To evaluate…
To test the hypothesis that mirikizumab is superior to placebo in maintaining clinical remission at Week 40 (Week 52 of continuous therapy) among patients induced into clinical remission with mirikizumab
The primary objective is to determine the safety, tolerability and feasibility of pre-surgical lyso-thermosensitive liposomal doxorubicin (ThermoDox) + MR-HIFU induced local hyperthermia therapy in metastatic breast cancer. The secondary objectives…
To assess the concurrent validity of the FastFocus* Vital Sign Monitoring System classification algorithm that discriminates between lying, sitting/standing, and walking activities, and detects number of walking steps in hospitalised patients under…